Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Dec 2025 for Kyverna Therapeutics, Inc., €852k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Westlake BioPartners Opportunity Fund I, L.P.: trading record in brief
Our data holds just one disclosure by Westlake BioPartners Opportunity Fund I, L.P., dated 22 December 2025, reporting an open-market purchase worth €852k in Kyverna Therapeutics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Westlake BioPartners Opportunity Fund I, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations0 total
▲
Same trade as the filing by Beth C. Seidenberg, counted once
999,998 USD22SEC
133,333 shares@ US$7.50100.0% of flowCommon StockSEC:0001104659-25-123596:0
Canonical exit: 18 Mar 2026 (T+90)
1 of 0 declarations
